| Severe cytokine release syndrome in a patient receiving PD‐1‐directed therapy SJ Rotz, D Leino, S Szabo, JL Mangino, BK Turpin, JG Pressey Pediatric blood & cancer 64 (12), e26642, 2017 | 155 | 2017 |
| Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and … Y Inamoto, N Valdés-Sanz, Y Ogawa, M Alves, L Berchicci, J Galvin, ... Bone marrow transplantation 54 (5), 662-673, 2019 | 89 | 2019 |
| Healthcare burden, risk factors, and outcomes of mucosal barrier injury laboratory-confirmed bloodstream infections after stem cell transplantation CE Dandoy, D Haslam, A Lane, S Jodele, K Demmel, J El-Bietar, L Flesch, ... Biology of Blood and Marrow Transplantation 22 (9), 1671-1677, 2016 | 71 | 2016 |
| ST2 and endothelial injury as a link between GVHD and microangiopathy SJ Rotz, CE Dandoy, SM Davies New England Journal of Medicine 376 (12), 1189-1190, 2017 | 58 | 2017 |
| Use of thrombopoietin receptor agonists in prolonged thrombocytopenia after hematopoietic stem cell transplantation U Mahat, SJ Rotz, R Hanna Biology of Blood and Marrow Transplantation 26 (3), e65-e73, 2020 | 53 | 2020 |
| A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant CE Dandoy, S Rotz, PB Alonso, A Klunk, C Desmond, J Huber, ... Blood advances 5 (1), 1-11, 2021 | 48 | 2021 |
| Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury–laboratory confirmed bloodstream infections in the first 100 days after allogeneic … CE Dandoy, S Kim, M Chen, KW Ahn, MI Ardura, V Brown, S Chhabra, ... JAMA network open 3 (1), e1918668-e1918668, 2020 | 47 | 2020 |
| Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia CJ Lee, S Kim, HR Tecca, S Bo-Subait, R Phelan, R Brazauskas, ... Blood advances 4 (6), 983-992, 2020 | 42 | 2020 |
| Pretransplant genetic susceptibility: clinical relevance in transplant-associated thrombotic microangiopathy E Gavriilaki, T Touloumenidou, I Sakellari, I Batsis, D Mallouri, ... Thrombosis and haemostasis 120 (04), 638-646, 2020 | 40 | 2020 |
| Sickle cell disease: A primary care update. G Onimoe, S Rotz Cleveland Clinic journal of medicine 87 (1), 19-27, 2020 | 40 | 2020 |
| Sex-specific cardiovascular risks of cancer and its therapies NS Wilcox, SJ Rotz, MK Mullen, EJ Song, B Ky Hamilton, J Moslehi, ... Circulation research 130 (4), 632-651, 2022 | 38 | 2022 |
| Limitations of HLH‐2004 criteria in distinguishing malignancy‐associated hemophagocytic lymphohistiocytosis A Gurunathan, AA Boucher, M Mark, KM Prus, MM O'Brien, EH Breese, ... Pediatric Blood & Cancer 65 (12), e27400, 2018 | 36 | 2018 |
| Thrombotic microangiopathy in cancer IC Weitz Seminars in Thrombosis and Hemostasis 45 (04), 348-353, 2019 | 34 | 2019 |
| A View from the past into our collective future: the oncofertility consortium vision statement TK Woodruff, L Ataman-Millhouse, KS Acharya, T Almeida-Santos, ... Journal of assisted reproduction and genetics 38, 3-15, 2021 | 32 | 2021 |
| A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation SW Benoit, BP Dixon, SL Goldstein, MR Bennett, A Lane, DT Lounder, ... Bone Marrow Transplantation 54 (9), 1453-1461, 2019 | 30 | 2019 |
| Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant SJ Rotz, TD Ryan, J Hlavaty, SA George, J El‐Bietar, CE Dandoy Pediatric Blood & Cancer 64 (11), e26600, 2017 | 30 | 2017 |
| Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation SJ Rotz, TD Ryan, SS Hayek Journal of thrombosis and thrombolysis 51, 854-869, 2021 | 28 | 2021 |
| Prevalence of sickle cell disease, hemoglobin S, and hemoglobin C among Haitian newborns S Rotz, G Arty, R Dall'Amico, L De Zen, F Zanolli, P Bodas American Journal of Hematology 88 (9), 827-828, 2013 | 28 | 2013 |
| Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence U Mahat, RB Matar, SJ Rotz Pediatric Blood & Cancer 66 (11), e27913, 2019 | 26 | 2019 |
| Unique challenges of hematopoietic cell transplantation in adolescent and young adults with hematologic malignancies PA Mehta, SJ Rotz, NS Majhail Biology of Blood and Marrow Transplantation 24 (12), e11-e19, 2018 | 25 | 2018 |
Christopher DandoyCincinnati Children's Hospital Medical CenterVerified email at cchmc.org
